Amneal Pharmaceuticals (AMRX) Other Working Capital Changes (2017 - 2026)

Amneal Pharmaceuticals' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at $13.4 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 2512.09% year-over-year to $13.4 million in Q1 2026; TTM through Mar 2026 was $32.0 million, a 413.11% increase from a year earlier, with the FY2025 full-year figure at $19.2 million, up 1898.23% from the prior year.
• Other Working Capital Changes advanced to $13.4 million in Q1 2026 per AMRX's latest filing, from -$1.0 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $115.3 million in Q2 2022 and bottomed at -$85.4 million in Q3 2022.
• The 5-year median for Other Working Capital Changes is -$1.0 million (2025), against an average of -$833764.7.
• Across the five-year window, Other Working Capital Changes plunged 2535.58% in 2022 and soared 2512.09% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at -$44.3 million in 2022, then jumped by 70.62% to -$13.0 million in 2023, then jumped by 91.36% to -$1.1 million in 2024, then gained by 10.06% to -$1.0 million in 2025, then soared by 1426.73% to $13.4 million in 2026.
• Per Business Quant, the three latest AMRX Other Working Capital Changes figures stand at $13.4 million (Q1 2026), -$1.0 million (Q4 2025), and $10.2 million (Q3 2025).